본 연구에서는 IL-$1{eta}$ 발현에 PG의 영향을 조사하였고, 단핵세포에서 PG에 의한 IL-$1{eta}$ 상향조절에 포함된 세포인자를 밝혔다. PG에 사람의 THP-1 세포를 노출시키면 IL-$1{eta}$ 분비 증가뿐만 아니라 IL-$1{eta}$ 유전자 전사를 유도하는 결과를 가져왔고, TLR-2/4의 억제제인 OxPAPC에 의해 저해되었다. U0126, SP6001250, Akti IV, rapamycin, DPI 같은 약리학적 저해제도 PG에 의한 IL-$1{eta}$의 상향조절을 상당히 약화시켰다. 그러나 polymyxin B는 IL-$1{eta}$ 발현에 영향을 미치지 않았다. 본 연구는 PG는 TLR-2, Akt, mTOR, MAPKs, ROS를 통하여 IL-$1{eta}$의 발현을 상향시킴을 확인하였다.
This study investigated the effects of PG on IL-$1{eta}$ expression and determined cellular factors involved in PG-mediated IL-$1{eta}$ up-regulation in mononuclear cells in order to understand the molecular mechanisms underlying inflammatory responses associated with bacterial pathogen-associated molecular patterns in the diseased artery. Exposure of human monocytic leukemia THP-1 cells to PG resulted in enhanced secretion of IL-$1{eta}$ and also profound induction of the IL-$1{eta}$ gene transcript. These effects were abrogated by OxPAPC, an inhibitor of TLR-2/4. Pharmacological inhibitors such as U0126, SP6001250, Akti IV, rapamycin, and DPI also significantly attenuated PG-mediated IL-$1{eta}$ up-regulation. However, polymyxin B did not influence the IL-$1{eta}$ expression. This study indicates that PG contributes to vascular inflammation in atherosclerotic plaques by up-regulating expression of IL-$1{eta}$ via TLR-2, Akt, mTOR, MAPKs, and ROS.
